Need Help? Call 1­-866-­796-­7386
« back to stock screener

  HALO stock: Halozyme Therapeutics, Inc.

Current Rating
Sell

Previous Rating

Hold/Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$44.71
Market Cap
4.52B
Sector
Health Care
Div. Growth
-
P/E
20.9
P/B
31.03
P/S
6.06
Dividend %
-
P/CF
37.1
P/FCF
16.9
Op. Cash Flow
305.9K
FCF
2.1
Op. Margin
39.20%
Net Margin
30.20%
ROE
193.30%
ROI
13.00%
ROA
13.00%
EPS Growth
-33.20%
Current Ratio
5.6
Debt/Equity
879.20%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Navidea Biopharmaceuticals Inc (NAVB) $0.03 - - 5M Strong Buy
CordovaCann Corp (LVRLF) $0.07 - - 12.6M Strong Buy
Owens & Minor, Inc. (OMI) $18.62 - - 1.19B Strong Buy
Airsculpt Technologies Inc (AIRS) $4.66 - - 339.6M Strong Buy
Aytu Biopharma Inc (AYTU) $2.94 - - 14.8M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More